Use the Back button in your browser to see the other results of your search or to select another record.
Prospective randomized single-blinded controlled clinical trial of percutaneous neuromodulation pain therapy device versus sham for the osteoarthritic knee: a pilot study |
Kang RW, Lewis PB, Kramer A, Hayden JK, Cole BJ |
Orthopedics 2007 Jun;30(6):439-445 |
clinical trial |
4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: No; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
This pilot study presents the initial results for a percutaneous neuromodulation pain therapy device (Neurowave) that is associated with no morbidity, good pain relief, and increased function in patients with knee osteoarthritis.
|